Table 1.
Patients descriptive characteristics.
| Variables | No Cancer (N = 1,559) | PCa (N = 1,018) | p-value | ISUP 1 PCa (N = 406) | p-value* | ISUP>1 PCa (N = 612) | p-value ** |
|---|---|---|---|---|---|---|---|
| Age (years) | 65 (60, 70) | 68 (63, 74) | <0.0001 | 67 (62, 72) | 0.001 | 70 (65, 75) | <0.0001 |
| Suspicious DRE | 33.8% (527) | 53.7% (547) | <0.0001 | 39.8%(162) | 0.065 | 62.8% (384) | <0.0001 |
| PSA (ng/mL) | 6 (5, 8) | 7 (5, 10) | 0.0002 | 6 (5, 8) | 0.041 | 7 (5, 11) | <0.0001 |
| PVol (mL) | 60 (44, 80) | 42 (32, 57) | <0.0001 | 47 (35, 61) | <0.0001 | 40 (30, 55) | <0.0001 |
| PVR (mL) | 40 (20, 70) | 20 (1, 50) | <0.0001 | 20 (1, 50) | <0.0001 | 22 (1, 50) | <0.0001 |
| PFR (mL/s) | 12 (8, 16) | 13 (10, 17) | <0.0001 | 14 (10, 18) | <0.0001 | 13 (9, 17) | <0.0001 |
Continuous variables are reported as medians (interquartile range); categorical variables are reported as rates (n).
*
ISUP 1 vs. no cancer.
**
ISUP >1 vs. no cancer. DRE, digital rectal examination; ISUP, International Society of Urological Pathology; PCa, prostate cancer; PFR, peak flow rate; PSA, prostate-specific antigen; PVol, prostate volume; PVR, post-void residual urinary volume. The bold values are the statistically significant differences.